CA-MISFIT
Misfit and Speedo today are announcing the launch of a Speedo-branded activity, swim, and sleep tracker — Speedo Shine. Speedo Shine will initially be available in retail exclusively at Apple stores worldwide on September 1st , as well as on misfit.com, and Speedo’s online stores — speedostore.com, speedostore.co.uk, speedostore.de , and speedostoreeu.com.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150818005258/en/
Speedo Shine is the first device of its kind that was designed with swimmers in mind. Proprietary lap counting algorithms embedded in the device’s firmware track a swimmer’s lap count with industry-leading accuracy and work for all stroke types. Speedo Shine syncs with the Misfit app for iOS and Android and displays laps and swim distance, along with calories burned and points earned. The device will soon also work with Speedo’s personalized swim tracking app, Speedo Fit.
Speedo Shine is endorsed by elite Speedo athlete, fitness ambassador, and Olympic Gold Medalist Missy Franklin. "One of the most difficult parts of swimming for fitness is keeping track of laps and the Speedo Shine eliminates that challenge,” said Franklin. “With the Speedo Shine, you can focus on getting the most out of your water workout and it’s also a great looking accessory to wear.”
Speedo Shine is made out of durable and beautiful aircraft-grade aluminum and is offered in new light silver color, Pure. Like the original Misfit Shine, Speedo Shine is waterproof to 50 meters. Extremely thin and comfortable, the device is meant to be worn both in and out of the water, and also tracks walking, running, cycling, and light and deep sleep. Since it never requires charging, Speedo Shine makes activity, sleep, and swim tracking a seamless experience.
Jamie Cornforth, Vice President of Product and Marketing at Speedo International said: “Speedo’s purpose is to inspire people to swim. The new Speedo Shine is a big step forward and will give swimmers the information they have always wanted, the ability to accurately track their laps, distance, calories and time. The new Speedo Shine also allows swimmers to take this information and seamlessly add it to their wider fitness data, providing an accurate and complete view of their total health and fitness regime. Swimming has always been a great way to improve your health and fitness — the Speedo Shine will now make swimming an even more valuable and effective experience.”
About Speedo
The world’s leading swimwear brand, Speedo is passionate about life in and around the water, creating revolutionary new technologies, designs and innovations and supporting swimming from grass-roots through to elite level. In the 1920s Speedo made history with the Racerback: the world’s first non-wool suit. In 2008 Speedo redefined swimwear again with Fastskin LZR RACER - the fastest and most technologically advanced swimsuit ever created. 2011 saw Speedo unveil another world first with the Fastskin Racing System - a cap, goggle and suit designed to work together as one. Speedo is owned by Speedo Holdings B.V and distributed in over 170 countries around the world; to find out more visit: www.speedo.com .
About Misfit
Misfit invents and manufactures wearable and smart home products. The company was founded in 2011 by Sonny Vu with John Sculley, the former CEO of Apple and Pepsi, and Sridhar Iyengar, co-founder and former CTO of AgaMatrix.
Misfit product images and videos: http://www.misfit.com/media
Copyright 2015 Misfit Inc. All rights reserved.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150818005258/en/
Contact:
Misfit
Amy Puliafito, +1 415-868-5249
apuliafito[at]misfit[dot]com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum